| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 6.42B | — |
| Operating expense | — | — |
| Net income | 1.48B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, NEULANDLAB.NS returned +68.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +50.5% |
| 1 year | +68.8% |
| 5 years | +1313.3% |
| 10 years | +2268.6% |
| All-time high | ₹23,301.00 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in NEULANDLAB.NS would be worth today ›Yes. Neuland Laboratories Limited paid 1 dividend over the past 12 months. The most recent was ₹34.00 per share on Jul 24, 2026. The dividend yield is 0.15%.
Neuland Laboratories Limited is part of the Healthcare sector.
Neuland Laboratories Limited has a market cap of 292.47B INR, based on the latest quote.
